Frontlight ResearchEarly access
Childhood cancers trials in China
609 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleGenetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
- Where
- Beijing
- Age
- 0 years to 18 years
- People
- 400
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT05672043 - No phaseTaking peopleClinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL
- Where
- Beijingcun
- Age
- 2 years to 70 years
- People
- 100
- Run by
- Hebei Senlang Biotechnology Inc., Ltd.
See details and how to joinNCT05626400 - No phaseTaking peopleA Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)
- Where
- Beijing
- Age
- Up to 55 years
- People
- 102
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT05603078 - Phase 1/2Not yet taking people in ChinaA Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma
- Where
- Beijing, Jinan, Shanghai
- Age
- 2 years to 25 years
- People
- 148 worldwide
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT05590572 - No phaseTaking peoplePrediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
- Where
- Beijing
- People
- 45
- Run by
- Peking University People's Hospital
See details and how to joinNCT05408897 - Phase 2Taking peopleOlverembatinib for FGFR1-rearranged Neoplasms
- Where
- Suzhou
- People
- 20
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT05521204 - No phaseTaking peopleChinese Colorectal Cancer Database
- Where
- Beijing
- People
- 200,000
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT05434026 - No phaseTaking peopleAssessment of Brain Cognitive Impairment in Breast Cancer
- Where
- Xi'an
- People
- 90
- Run by
- Tang-Du Hospital
See details and how to joinNCT05305092 - Phase 2Not yet taking people in ChinaAllogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma
- Where
- Guangzhou
- Age
- Up to 18 years
- People
- 64
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05303727 - No phaseTaking peopleNovel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
- Where
- Jinan
- People
- 300
- Run by
- Qianfoshan Hospital
See details and how to joinNCT05214885 - Early phase 1Taking peopleCD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
- Where
- Hangzhou
- People
- 108
- Run by
- Zhejiang University
See details and how to joinNCT04662294 - Phase 3Taking peopleAdjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
- Where
- Guangzhou
- People
- 500
- Run by
- Sun Yat-sen University
See details and how to joinNCT05080010 - Phase 2/3Taking peopleValue of LNG-IUS as Fertility-preserving Treatment of EAH and EC
- Where
- Chengdu
- Age
- Up to 40 years
- People
- 224
- Run by
- West China Second University Hospital
See details and how to joinNCT03463252 - No phaseTaking peopleGastric Cancer Marker Detection and Its Kit Development
- Where
- Wenzhou
- People
- 530
- Run by
- Second Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT05010863 - No phaseTaking peopleLong-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry
- Where
- Shanghai
- People
- 500,000
- Run by
- Fudan University
See details and how to joinNCT04996732 - Phase 1/2Taking peopleSingle Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer
- Where
- Shanghai
- People
- 120
- Run by
- Fudan University
See details and how to joinNCT04947280 - Phase 3Taking peopleTopotecan and Melphalan for Retinoblastoma
- Where
- Guangzhou
- People
- 50
- Run by
- Sun Yat-sen University
See details and how to joinNCT04799002 - No phaseTaking peopleMR Based Survival Prediction of Glioma Patients Using Artificial Intelligence
- Where
- Zhengzhou
- Age
- 1 year to 90 years
- People
- 2,500
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT04215211 - No phaseTaking peopleHistopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence
- Where
- Zhengzhou
- Age
- 1 year to 90 years
- People
- 3,500
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT04215224 - No phaseTaking peopleMR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence
- Where
- Zhengzhou
- Age
- 1 year to 95 years
- People
- 3,000
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT04217018 - No phaseTaking peopleHistopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence
- Where
- Zhengzhou
- Age
- 1 year to 95 years
- People
- 3,000
- Run by
- The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT04217044 - Early phase 1Taking peopleA Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy
- Where
- Hangzhou
- Age
- 3 years to 70 years
- People
- 72
- Run by
- He Huang
See details and how to joinNCT04227015 - Early phase 1Not yet taking people in ChinaClinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies
- Where
- Hangzhou
- Age
- 15 years to 60 years
- People
- 36
- Run by
- Zhejiang University
See details and how to joinNCT04662788 - Early phase 1Not yet taking people in ChinaLMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies
- Where
- Hangzhou
- People
- 144
- Run by
- Zhejiang University
See details and how to joinNCT04657965 - Early phase 1Not yet taking people in ChinaNKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
- Where
- Hangzhou
- Age
- 3 years to 70 years
- People
- 36
- Run by
- Zhejiang University
See details and how to joinNCT04658004